JUAN TAMARGO MENÉNDEZ-rekin lankidetzan egindako argitalpenak (7)

2022

  1. Ranolazine: a better understanding of its pathophysiology and patient profile to guide treatment of chronic stable angina

    Future cardiology, Vol. 18, Núm. 3, pp. 235-251

  2. Tbx5 variants disrupt Nav1.5 function differently in patients diagnosed with Brugada or Long QT Syndrome

    Cardiovascular research, Vol. 118, Núm. 4, pp. 1046-1060

2020

  1. Comparison of noninvasive cardiac test strategies for newly diagnosed chagas disease in a non-endemic zone

    American Journal of Tropical Medicine and Hygiene, Vol. 103, Núm. 4, pp. 1480-1486

2017

  1. Pharmacological reasons that may explain why randomized clinical trials have failed in acute heart failure syndromes

    International Journal of Cardiology, Vol. 233, pp. 1-11

  2. Tbx20 controls the expression of the KCNH2 gene and of hERG channels

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, Núm. 3, pp. E416-E425

2016

  1. Management of stable angina: A commentary on the European Society of Cardiology guidelines

    European Journal of Preventive Cardiology, Vol. 23, Núm. 13, pp. 1401-1412

2015

  1. Unresolved issues in the management of chronic stable angina

    International Journal of Cardiology, Vol. 201, pp. 200-207